A Study of Ad-RTS-hIL-12 With Veledimex in Combination With Nivolumab in Subjects With Glioblastoma; a Substudy to ATI001-102
Clinical trial NCT03636477 · COMPLETED
Trial details
- NCT number
- NCT03636477
- Sponsor
- Alaunos Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-18
- Primary completion
- 2020-10-15
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.